Your browser doesn't support javascript.
loading
Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectories.
Gezsi, Andras; Van der Auwera, Sandra; Mäkinen, Hannu; Eszlari, Nora; Hullam, Gabor; Nagy, Tamas; Bonk, Sarah; González-Colom, Rubèn; Gonda, Xenia; Garvert, Linda; Paajanen, Teemu; Gal, Zsofia; Kirchner, Kevin; Millinghoffer, Andras; Schmidt, Carsten O; Bolgar, Bence; Roca, Josep; Cano, Isaac; Kuokkanen, Mikko; Antal, Peter; Juhasz, Gabriella.
Afiliação
  • Gezsi A; Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.
  • Van der Auwera S; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Mäkinen H; German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
  • Eszlari N; Department of Public Health and Welfare, Population Health Unit, Public Health Research Team, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Hullam G; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
  • Nagy T; NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
  • Bonk S; Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.
  • González-Colom R; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
  • Gonda X; Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.
  • Garvert L; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
  • Paajanen T; NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
  • Gal Z; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Kirchner K; Clínic Barcelona, Fundació de Recerca Clinic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • Millinghoffer A; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
  • Schmidt CO; NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
  • Bolgar B; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Roca J; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Cano I; Department of Public Health and Welfare, Population Health Unit, Public Health Research Team, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Kuokkanen M; Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
  • Antal P; NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
  • Juhasz G; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Nat Commun ; 15(1): 7190, 2024 Aug 21.
Article em En | MEDLINE | ID: mdl-39168988
ABSTRACT
The heterogeneity and complexity of symptom presentation, comorbidities and genetic factors pose challenges to the identification of biological mechanisms underlying complex diseases. Current approaches used to identify biological subtypes of major depressive disorder (MDD) mainly focus on clinical characteristics that cannot be linked to specific biological models. Here, we examined multimorbidities to identify MDD subtypes with distinct genetic and non-genetic factors. We leveraged dynamic Bayesian network approaches to determine a minimal set of multimorbidities relevant to MDD and identified seven clusters of disease-burden trajectories throughout the lifespan among 1.2 million participants from cohorts in the UK, Finland, and Spain. The clusters had clear protective- and risk-factor profiles as well as age-specific clinical courses mainly driven by inflammatory processes, and a comprehensive map of heritability and genetic correlations among these clusters was revealed. Our results can guide the development of personalized treatments for MDD based on the unique genetic, clinical and non-genetic risk-factor profiles of patients.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teorema de Bayes / Transtorno Depressivo Maior / Multimorbidade Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teorema de Bayes / Transtorno Depressivo Maior / Multimorbidade Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article